Dr. Sukesh C. Burjonroppa, MD

Dr. Burjonroppa practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Burjonroppa's NPI, 1467599134, was assigned on January 31, 2007. Dr. Burjonroppa graduated from Bangalore Medical College in 1998. Dr. Burjonroppa's Texas license number on file is M9891.

Dr. Burjonroppa's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Burjonroppa's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Burjonroppa is also affiliated with Texas Health Southwest Fort Worth. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Burjonroppa to 3 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burjonroppa practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Burjonroppa's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Burjonroppa is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Burjonroppa's licenses on file in 3 states: Texas, California and Pennsylvania.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization and pacemaker or defibrillator implantation among the conditions Dr. Burjonroppa treats.

CMS data shows 3,648 Medicare services from Dr. Burjonroppa across 39 procedure codes in 2024, for 646 Medicare patients. Medicare paid $301,683 for them.

CMS counts 646 Medicare patients who saw Dr. Burjonroppa in 2024. The largest group is 75 to 84, with 273 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Burjonroppa's median patient age at 73, with 44% women.

In 2024, Dr. Burjonroppa wrote 1,990 Medicare Part D claims for 378 patients. 85% of them were for generic drugs. CMS names the drug for 1,870 of them, across 35 drugs with 11 or more claims each, at $265,194 in total drug cost. In 2023, CMS named 2,222 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Burjonroppa for performance year 2024, reported individually. Dr. Burjonroppa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Burjonroppa as offering telehealth. CMS counts 65 procedures of coronary angioplasty and stenting by Dr. Burjonroppa, more than 90% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Burjonroppa in 2010. The most frequent topics are Myocardial Infarction, Angioplasty, Balloon, Coronary and Echocardiography, Transesophageal. Dr. Burjonroppa has published most often in J Interv Cardiol. Dr. Burjonroppa's most frequent co-authors are Andrew John Boyle, MD, Richard W. Smalling, MD and Fernando Boccalandro, MD.

CMS Open Payments shows 760 general payments to Dr. Burjonroppa from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Medtronic Vascular, Inc. paid the most, $133,262.

Dmand AI lists 2 awards for Dr. Burjonroppa, most recently CMS Stage 1 EHR in 2013.

Dr. Burjonroppa graduated from Bangalore Medical College in 1998. Dr. Burjonroppa is a member of ACC.

Dr. Burjonroppa is in network with 22 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.